Latest Market Access News

OncoSil Medical Limited has announced a fully underwritten $2 million entitlement offer alongside a $6 million placement to fund its clinical and commercial growth initiatives. The capital raising includes new shares and options, with shareholder approvals pending for certain components.

OncoSil Medical secures $8 million in capital to fund a pivotal German government-sponsored clinical trial and accelerate its European commercial expansion.

Nimy Resources reveals a significant extension to its Block 3 gallium deposit in Western Australia, with a high-resolution magnetic survey indicating a 3.5km strike beyond the current resource boundary. The company is also advancing metallurgical test work and seeking federal funding to support development.

Resolution Minerals has taken a significant step towards expanding its footprint in the US capital markets by lodging a registration statement with the SEC and launching an ADR facility, while divesting a non-core Alaskan asset to focus on key US projects.

CurveBeam AI has received the first A$4 million tranche of a planned A$10 million strategic investment from a leading Chinese orthopaedic device company, marking a significant step in its expansion into the Chinese market.

Orthocell Ltd reports steady progress in commercialising its nerve repair product Remplir in the US, with sales growth, expanded distributor networks, and manufacturing upgrades underpinning its path to profitability.

Australian Bond Exchange Holdings (ABE) has successfully completed live testing in the Reserve Bank of Australia's CBDC pilot, expanded its product offerings, and reported improved cash flow in Q2 FY26.

G50 Corp has initiated core drilling at its Golconda Project amid a sharp rise in gallium, gold, and silver prices, while preparing to drill at White Caps. The company’s upgrade to OTCQX aims to boost U.S. investor access, complemented by recent board changes.

ReNerve Limited reported a robust 80% increase in quarterly sales driven by strong US market adoption and expanded hospital approvals. The company advances its nerve repair product pipeline with key regulatory milestones and a refreshed board.

Medallion Metals has completed a pivotal feasibility study for its Ravensthorpe Gold Project and raised $60 million to accelerate development, while progressing a key acquisition of Forrestania assets.

Terragen Holdings reports a strong quarter with an 87% increase in sales of its ruminant probiotic and advances key livestock and crop trials, positioning itself for expanded market access.

Yugo Metals has made promising progress with diamond drilling at its Sinjakovo project, intersecting silver-zinc-lead mineralisation, while securing $3.5 million in new funding and expanding its investor reach through a dual listing in Germany.